|
 |
StratteraThis page contains recent news articles, when available, and an overview of Strattera but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Strattera (when available) Atomoxetine is an amphetamine used to treat ADD/ADHD in children and adults. Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity. It increases motor activity and mental alertness, and reduces drowsiness and a sense of fatigue, decreasing motor restlessness and improves one's ability to focus. Peripheral actions include elevation of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action. There is neither specific evidence which clearly establishes the mechanism whereby amphetamine produces mental and behavioral effects in children, nor conclusive evidence regarding how these effects relate to the condition of the central nervous system. Atomoxetine activates the brain stem arousal system and cortex to produce its stimulant effect. For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). Mechanism Of Action: Amphetamines release stores of norepinephrine and dopamine from nerve endings by converting the respective molecular transporters into open channels. Amphetamines also releases stores of serotonin from synaptic vesicles. Like methylphenidate (Ritalin) amphetamines also prevent the monoamine transporters for dopamine and norepinephrine from recycling them (called reuptake inhibition) which leads to increased amounts of dopamine and norepinephrine in synaptic clefts. These combined effects rapidly increases the concentrations of the respective neurotransmitters in the synaptic cleft, which promotes nerve impulse transmission in neurons that have those receptors. News Articles on Atomoxetine Biotech/Pharma Docket - 05 Jan 2010 ...these generic versions would induce others to infringe, as the infringing use is the only method for using Strattera® that has been approved by the FDA. ... Patent Docs (blog) Glenmark Generics gets tentative USFDA nod for 2 drugs - Dec 24, 2009 The company has also received tentative approval from USFDA for Atomoxetine Hydrochloride capsules, the generic version of Lilly`s Strattera. Myiris.com Facing Stunted Growth in ADHD Market, Shire Clicks on Twitter - Dec 31, 2009 Pharma received tentative first-to-launch approval from the FDA for atomexetine — Strattera (US sales of $437.8 million in 2008 for Eli Lilly). ... BNET FDA Grants Tentative Approval To GGI For Pramipexole Dihydrochloride Tablets - Dec 28, 2009 GGI also received tentative approval for Atomoxetine Hydrochloride capsules, the generic version of Lilly's Strattera. Atomoxetine Hydrochloride capsules is ... Pharmaceutical Business Review Attention Deficit Disorder can affect both children, adults - Dec 31, 2009 There are other non-stimulant classes of drugs (Strattera, Adderol, etc.) which may have certain advantages and disadvantages. ... Mirror Glenmark subsidiary gets nod for Boehringer Ingelheim's drug - Dec 24, 2009 The subsidiary has also received tentative approval for Atomoxetine Hydrochloride capsules, the generic version of Lilly's Strattera. ... Business Standard Oxycodone raid ends with guilty plea for Kenova man - Dec 15, 2009 The 83 pills were oxycodone, Adderall, methadone, Strattera, tunesta and prednisone. Other confiscated items included electronic scales, two cell phones, ... Huntington Herald Dispatch Glenmark Pharma makes a mark after US nod for generic drugs - Dec 24, 2009 Atomaxetine hydrochloride capsule is the generic version of Lilly's Strattera and is used for treating attention-deficit/ hyper activity disorder. ... India Infoline.com Key trends driving the global ADHD disease drug market - Dec 10, 2009 Strattera, Intuniv and Vyvanse have better safety and efficacy profiles than the other ADHD drugs. The authors research shows that the products currently ... News-Medical.net Why Are We Drugging Our Kids? - Dec 14, 2009 ADHD drug prices at a middle dose for 90 pills at DrugStore.com, are: Adderall $278, Concerta $412, Desoxyn $366, Strattera $464 and Vyvanse $385. ... AlterNet Boost je blok: studiebevorderende middelen - Dec 13, 2009 Minder bekende namen zijn Provigil (op basis van modafinil) en Strattera (op basis van atomoxetine). Het eigenlijke gebruik van deze middelen dient onder ... Veto FamilienNews: ADHS: Immer mehr Kinder schlucken Pillen - Dec 10, 2009 ...bei ihr Versicherten zwischen sechs und 18 Jahren ein Medikament wie Ritalin oder Strattera gegen das sogenannte Zappelphilipp-Syndrom verordnet worden. ... Berliner Morgenpost Immer mehr Kinder mit Zappelphilipp-Syndrom - Dec 31, 2009 Jungen wurden viermal so häufig mit den Arzneimitteln Ritalin und Strattera behandelt wie Mädchen. Untersucht wurden die Arzneimittelverordnungen an Kinder ... shz DAK warnt: Immer mehr Kinder nehmen Medikamente gegen ADHS - Dec 10, 2009 ...den Wirkstoff Methylphenidat, der beispielsweise in dem Medikament Ritalin enthalten ist, oder den Wirkstoff Atomoxetin, zum Beispiel in Strattera. ... Welt Online RZ-Thema - Dec 14, 2009 Im vergangenen Jahr schluckten 3,1 Prozent der bei der Kasse versicherten Kinder Arzneien wie Ritalin mit dem Wirkstoff Methylphenidat oder Strattera mit ... Rhein Zeitung Police seek axe-wielding robber in Falmouth - Oct 30, 2009 Police said the man took the woman's purse along with percocet and strattera, which is used to treat Attention Deficit Hyperactivity Disorder. ... Boston Herald Cadila gets USFDA nod for Atomoxetine Hydrochloride capsules - Nov 3, 2009 Atomoxetine Hydrochloride Capsules are generic equivalent to Strattera of Eli Lily and company. The capsules are indicated for treatment of ... Myiris.com Aurobindo Pharma pares early losses on US nod for generic drug - Nov 11, 2009 Atomoxetine Hydrochloride is the generic version of Strattera of Eli Lily and Company. The drug is used for treating attention-deficit/ hyperactivity ... India Infoline.com REG-Lilly (Eli) & Co: Lilly Rpts Solid 3Q09; Rev Full-Year 09 EPS Guidance - Oct 21, 2009 Strattera During the third quarter of 2009, Strattera generated $145.5 million of sales, a decrease of 3 percent compared with the third quarter of 2008. ... Reuters Eli Lilly earnings preview - Oct 19, 2009 It expects Lackluster performance from Zyprexa (-3% to $1.150 billion), Gemzar, Evista, Erbitux US, Strattera and Xigris. ... The Daily Deal US nod for generic drug boosts Aurobindo Pharma - Nov 5, 2009 Atomoxetine Hydrochloride is the generic version of Strattera of Eli Lily and Company. The drug is used for treating attention-deficit/ hyperactivity ... India Infoline.com ADHD Treatments To Be Compared In Public Webinar - Nov 2, 2009 ...“In our webinar, we will provide an unbiased view of ADHD treatments, including prescription drugs such as Adderall® and Strattera®, behavioral therapies, ... PR Web (press release) ADHD-DROGER OCH ANTIDEPRESSIVA BAKOM NYTT MYCKET GROVT VÃ…LDTÄKTSFALL - Nov 10, 2009 De svenska domstolarna fÃ¥r alltfler fall där psykiatriker skrivit ut icke godkända vÃ¥ldsframkallande ADHD-droger (Ritalina, Concerta, Strattera) till ... MyNewsdesk (pressmeddelande) Ett bättre stöd till barn som misslyckas i skolan - Nov 5, 2009 PÃ¥ psykkliniken i Växjö genomfördes för nÃ¥gra Ã¥r sedan kliniska prövningar pÃ¥ Strattera (Atomoxetin) ett ADHD-preparat som sedan 2007 godkänts för ... Smålandsposten BARN FÖRGIFTADE AV PSYKOFARMAKA – UPPSVÄLLDA KROPPAR, FÖRHÖJDA BLODFETTER OCH ... - Nov 9, 2009 I takt med att allt fler unga fÃ¥r Concerta, Ritalina och Strattera ökar ocksÃ¥ antalet som drabbas av psykotiska reaktioner och aggression - barnen bli dÃ¥ ... MyNewsdesk (pressmeddelande) Lilly to add suicide warning to drug Strattera - Sep 29, 2005 By Val Brickates Kennedy, MarketWatch. BOSTON (MarketWatch)-Eli Lilly said early Thursday that at the request of the Food and Drug Administration, ... MarketWatch Lilly's Strattera treats reading disorder - Oct 27, 2006 INDIANAPOLIS, Oct. 27 (UPI) -- US firm said Friday its drug Strattera appears effective in treating both attention deficit and reading disorders in children ... United Press International Eli Lilly gets FDA approval for ADHD drug Strattera - May 8, 2008 BOSTON (Thomson Financial) - Eli Lilly & Co. said Thursday the Food and Drug Administration has approved its Strattera treatment for ... Forbes ADHD Drugs Catch a Break - Mar 22, 2006 Neither is Lilly's Strattera, a drug on the market since 2003. Strattera carries a black box warning that it could cause suicidal thinking among adolescents ... TheStreet.com - TheStreet.com (subscription) Lilly Drug Stumbles on Label, Competitor Fallout - Apr 12, 2005 That's the story of Strattera, an Eli Lilly (LLY - commentary - Cramer's Take) drug ... Strattera is approved in the US for treating ADHD in adults and in ... TheStreet.com - TheStreet.com (subscription) Free drug samples may not be a great deal - Oct 6, 2008 Correction ran 10/22/2008: The drug Strattera, used to treat attention deficit/hyperactivity disorder in children and adults, is not a controlled substance. ... Pay-Per-View - USA TODAY - ProQuest Archiver ADHD drug earns subsidy despite suicidal side effects - Apr 13, 2007 Health Minister Tony Abbott announced yesterday that Strattera would be added to ... Mr Abbott said about 18000 people would take Strattera during its first ... The Australian FDA Approves Strattera(R) For Maintenance Of ADHD In Children And … - May 10, 2008 Eli Lilly and Company (NYSE: LLY) announced that the United States Food and Drug Administration (FDA) has approved Strattera(R) (atomoxetine HCI) for ... Medical News Today - Medical News Today (press release) Cephalon Overcomes Sparlon Scare - Mar 1, 2006 Strattera, available since 2003, already has a black-box warning that describes the risks of suicidal thinking among children and adolescents and a strong ... TheStreet.com - TheStreet.com (subscription) Two Picks In Big Pharma Ahead Of Q3 Earnings - Oct 12, 2005 ..."We are leaving our Strattera numbers unchanged for now, although pending ongoing review, following a recent label change that added the increased risk of ... Forbes Government subsidy for drug linked to suicide - Apr 12, 2007 Health Minister Tony Abbott announced yesterday that Strattera would be added to ... Mr Abbott said about 18000 people would take Strattera during its first ... NEWS.com.au Addictive drugs still best option for attention deficit disorder - Mar 29, 2006 The word on the street amongst physicians is that Strattera is a second-choice drug ... In 2002, Eli Lilly released the nonstimulant Strattera, which boosts ... Nature.com FDA to Go Slow on ADHD Drug Warnings - Jul 1, 2005 Strattera, another ADHD drug, is not a stimulant. Strattera's maker, Eli Lilly, is also a WebMD sponsor. The agency received 135 reports of side effects in ... FOXNews RPT-US criticizes Lilly, J&J, Shire for misleading drug ads - Sep 26, 2008 The FDA said a sales aid from Lilly overstated the effectiveness of its drug Strattera and minimized important risks. It also suggested use for patients for ... Reuters Lilly Sues India's Sun Pharma to Block Strattera Copy - Sep 24, 2007 By Susan Decker. Sept. 24 (Bloomberg) -- Eli Lilly & Co., the world's largest maker of psychiatric medicines, sued India's Sun Pharmaceutical Industries ... Bloomberg Side-effect doubts over child drug - Dec 8, 2006 The drug, Strattera, was the probable cause of one child's explosive mood swings ... Strattera works by regulating levels of the neurotransmitter chemical ... The Age Atomoxetine (Strattera) for attention deficit hyperactivity disorder - Apr 17, 2008 Atomoxetine (Strattera) strengthens the chemical signals between brain cells and also increases certain brain chemicals, called neurotransmitters, ... WebMD A Weekly Shot of News and Notes - Oct 4, 2005 STRATTERA, KIDS, SUICIDE Eli Lilly and Co. last week said it will add strong ... Strattera will now carry a "black box" warning, the strongest required by ... Pay-Per-View - Washington Post - ProQuest Archiver FDA Issues Advisory on Lilly's Strattera.(Food and Drug Administration... - Oct 10, 2005 The US Food and Drug Administration has issued a Public Health Advisory to alert physicians of reports of suicidal thinking in children and adolescents ... $4.95 - Pharma Marketletter - ECNext New drugs for hyperactive children raise doctors' fears - Apr 2, 2006 A report into Strattera by the Medicines and Healthcare Products Regulatory Agency said two British children had attempted suicide after taking it. ... Telegraph.co.uk Study Suggests Strattera(R) Improved ADHD Symptoms In Patients With … - May 24, 2007 Data from a recent clinical study showed Strattera(R) (atomoxetine HCl) improved symptoms of Attention- Deficit/Hyperactivity Disorder (ADHD) in patients ... Medical News Today - Medical News Today (press release) Children's suicide attempts raise concerns about ADHD medication - Jul 3, 2008 It is not the first time concern has been raised about Strattera, ... "If you're a parent and your kid gets prescribed Strattera, do you know that drug ... Globe and Mail Strattera.(Drug overview) - Jan 22, 2007 Strattera is used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD), a condition marked by either constant activity, a persistent ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Liver alert on hyperactivity drug - Feb 3, 2005 Strattera was licensed for the treatment of attention deficit hyperactivity ... "Some 2.3 million patients have been prescribed Strattera and less than 50 ... BBC News ADD Drug Strattera, Already Under FDA Scrutiny, Raising New Safety … - Feb 21, 2006 Although pharmaceutical giant Eli Lilly (Lilly) continues to maintain that its attention deficit drug, Strattera, is safe, the company’s actions as well ... Newsinferno.com Study Shows Children With ADHD Who Start on Strattera(R) are More … - Apr 10, 2007 ST. PAUL, Minn., April 10 /PRNewswire/ -- Pharmacy benefit manager Prime Therapeutics (Prime) today announced the results of a study on the utilization of ... Free with registration - PR Newswire - AccessMyLibrary.com Strattera (Atomoxetine), Non-Stimulant Medication For Attention... - Jan 6, 2005 TORONTO, ON -- January 6, 2005 -- Stratteraâ„¢ (atomoxetine) is the first and only non-stimulant medication ever approved in Canada for the treatment of ... DG News Gov't adds two new ADHD drugs to formulary to combat Ritalin abuse - Jul 18, 2008 Strattera is an alternative to Concerta, and does not contain the methylphenidate — the ingredient sought by drug abusers. Because it contains a weaker drug ... Canada.com State Blames UCI Hospital in Patient Suicide; An 18-year-old in the … - Mar 17, 2006 A UCI doctor gave the patient Zoloft, an antidepressant, and Strattera, a drug used to ... The doctor, who was not named, prescribed Strattera because of ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Lilly Profit Rises on Sales of Newer Drugs - Oct 21, 2005 Sales of Lilly's treatment for attention deficit disorder, Strattera, fell 14 percent, to $140.9 million from a year ago. In late September, Lilly announced ... New York Times Study Suggests Strattera® Was Effective In Treating ADHD In Children ... - Nov 3, 2006 New data suggest that Strattera® (atomoxetine HCl) improved ADHD symptoms in children and adolescents who had both ADHD and a reading disorder, ... Medical News Today - Medical News Today (press release) US drug companies warned over misleading ads | HEALTH News - Sep 27, 2008 The FDA said a sales aid from Lilly overstated the effectiveness of its drug Strattera and minimized important risks. It also suggested use for patients for ... TVNZ … : Study Shows Children With ADHD Who Start on Strattera(R) are More... - Apr 10, 2007 Study Shows Children With ADHD Who Start on Strattera(R) are More Likely to Change Therapies. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Lilly Makes Bid for Respect | Robert Steyer News | Print Financial & ... - Jul 20, 2005 But Lilly is still coping with weakening US sales of Zyprexa, its best-selling drug, and with disappointing sales of Strattera, a treatment for attention ... TheStreet.com - TheStreet.com (subscription) Strattera - 130 Reports Of Suicidality In One Mont - Feb 17, 2006 A not yet released discussion paper written by the British Medicines and Healthcare Regulatory Agency, reveals that last fall, there were 130 reports of ... scoop.co.nz … : LILLY (ELI) & COMPANY - FDA Approves Strattera for Maintenance of... - May 8, 2008 LILLY (ELI) & COMPANY - FDA Approves Strattera for Maintenance of ADHD. from PR Newswire UK Disclose. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire UK Disclose - HighBeam Research FDA Issues Advisory on ADHD Drug Strattera - Sep 29, 2005 FDA warnings are generally "very positive and very necessary," says Rothe. However, he says those warnings often get blown out of proportion by the media ... WebMD US FDA calls for new warnings on ADHD drugs - Aug 22, 2006 Ms Bro could not confirm whether other ADHD drugs - Johnson & Johnson's Concerta and Eli Lilly and Co's Strattera - also were ordered to carry the warnings. ... NEWS.com.au Profit Rises, but Eli Lilly Offers a Warning - Apr 19, 2005 ...eroding sales of its antipsychosis drug Zyprexa and its attention deficit disorder treatment Strattera, which has a new warning about side effects. ... New York Times Strattera benefits are less attentional than unintentional - Apr 17, 2007 Strattera has been found by many clinicians to have questionable efficacy in treating ADD/ADHD. However, there are redeeming virtues to this medication ... Gerson Lehrman Group Strattera.(New & Approved) | Article from Family Practice News | … - Jun 15, 2008 Strattera.(New & Approved) ... find Family Practice News articles. StraRera (atomoxetine HCI, Eli Lilly & Co.) The Food and Drug Administration approved ... Pay-Per-View - Family Practice News - HighBeam Research Pharma ads should have us all losing sleep - Apr 30, 2006 ...sleeping medications Ambien, time- release Ambien CR and Lunesta; statins known as Lipitor and Crestor; and the attention-deficit medication Strattera. ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Lilly Has $2.4 Mln Loss on Tax Costs; Sales Rise 5% - Jan 26, 2005 Sales rose 5 percent, boosted by attention-deficit drug Strattera and cancer treatment ... Newer medicines such as Strattera, Alimta for cancer and the ... Bloomberg Strattera.(New & Approved) | Article from Pediatric News | HighBeam … - Jun 1, 2008 Strattera.(New & Approved) ... find Pediatric News articles. Strattera (atomoxetine HCl, Eli Lilly & Co.) The Food and Drug Administration approved ... Pay-Per-View - Pediatric News - HighBeam Research ADDITIONAL WARNINGS SOUGHT ON ADHD DRUGS - Feb 22, 2007 The makers of Ritalin, Adderall, Strattera and other drugs treating attention deficit hyperactivity disorder were advised by the government Wednesday to ... $2.95 - San Jose Mercury News - NewsBank The ADHD drug Strattera: Lilly to issue warnings - Apr 28, 2008 The manufacturer, Eli Lilly, is to change the label for Strattera in Europe to include warnings about onset of “psychotic reactions, hallucinations, ... TransWorldNews - TransWorldNews (press release) FDA Issues Warning About ADHD Drug Strattera - Mar 27, 2006 FDA has issued a public health alert about the increased risk of suicidal thinking in children and teens being treated with Strattera. ... emaxhealth.com Lilly adding black-box warning to ADHD drug Strattera - Oct 7, 2005 Eli Lilly is adding a black-box warning to its attention deficit/hyperactivity disorder (ADHD) drug Strattera to reflect an increased risk of suicidal ... PR Week - PRWeek Atomoxetine hydrochloride (generic): Strattera (Brand).(YOUR … - Apr 1, 2007 COMMON USAGE: Atomoxetine (Strattera) is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. ... Free with registration - Brown University Child and Adolescent... - AccessMyLibrary.com Lilly adds liver warning to Strattera label.(Eli Lilly and Co.) - Jan 3, 2005 The USA's Eli Lilly has added a safety warning, in bold, to the label of Strattera (atomoxetine HCl), the first non-stimulant treatment for ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Warning of liver damage risk for atomoxetine (Strattera).(From the... - Feb 1, 2005 The FDA has asked Eli Lilly to update labels with a bolded warning about the risk of severe liver injury associated with the use of atomoxetine (Strattera), ... Free with registration - Brown University Geriatric Psychopharmac... - AccessMyLibrary.com Official warnings issued: The ADHD drug Strattera CAUSES - Dec 1, 2008 The manufacturer, Eli Lilly, has now changed the label for Strattera in Europe to include warnings that Strattera CAUSES “hallucinations, ... TransWorldNews - TransWorldNews (press release) Request submitted for an urgent safety review of the ADHD drug Stratte... - May 18, 2006 UK is the Reference Member State for Strattera in Europe. The information above warrants an urgent safety review. A request has been submitted to the ... 24-7pressrelease.com Article: Expanding adult market might boost Strattera sales - Oct 3, 2005 Sagging sales of Eli Lilly and Co.'s Strattera drug could get a lift from research that found prescriptions for attention deficit hyperactivity disorder are ... Pay-Per-View - Indianapolis Business Journal - HighBeam Research Warning on Strattera for attention-deficit hyperactivity disorder.(Eli... - Nov 1, 2005 A Public Health Advisory has been issued by the FDA to alert physicians to reports of suicidal thinking in children and adolescents associated with ... $4.95 - FDA Consumer - ECNext Lilly's Strattera added to Australian PBS. - Apr 30, 2007 Lilly's Strattera added to Australian PBS. What is viewed by some as a controversial treatment for attention-deficit hyperactivity disorder has been added ... $9.94 - Pharma Marketletter - Alacra Store A Weekly Shot of News and Notes | Article from The Washington Post | ... - Oct 4, 2005 STRATTERA, KIDS, SUICIDE Eli Lilly and Co. last week said it will add strong warnings to its label for Strattera, a drug... Pay-Per-View - Washington Post - HighBeam Research The ADHD drug Strattera – 55 young persons have died - Apr 13, 2008 New reports indicate that 55 children and teenagers have died while “treatedâ€? with the ADHD drug Strattera, in the last 5 years – 31 of them committed ... TransWorldNews - TransWorldNews (press release) Non-stimulant Strattera More Widely Available for Attention- Deficit/... - May 18, 2005 INDIANAPOLIS, May 18 /PRNewswire-FirstCall/ -- Eli Lilly and Company's Strattera(R) (atomoxetine HCl), the only approved non-stimulant medication proven ... $4.95 - PR Newswire - ECNext Strattera Safety Helped by DNA Testing, According to FDA Approved … - Mar 9, 2005 SEATTLE, March 9 /PRNewswire/ -- Stratterra, was recently approved by the FDA for the treatment of ADHD (attention-deficit/hyperactivity disorder) in ... Free with registration - PR Newswire - AccessMyLibrary.com Article: FDA Warns About ADHD Drug Strattera - AP Online | HighBeam … - Sep 30, 2005 FDA Warns About ADHD Drug Strattera ... find AP Online articles. JOHN J. LUMPKIN, Associated Press Writer AP Online 09-30-2005 Dateline: WASHINGTON The Fo. Pay-Per-View - AP Online - HighBeam Research Medical matters: Strattera is ok for ADHD.(attention deficit hyperacti... - Feb 25, 2006 Strattera (atomoxetine) may be used in children with attention- deficit/hyperactivity disorder, the UK drug regulator has concluded. ... Free with registration - Chemist & Druggist - AccessMyLibrary.com Strattera And Prozac Are The Same SSRI's - May 28, 2007 When both products where metabolised by digestion, both active phenylpropylamines acts in a similar way as the amphetamines act. ... Medical News Today - Medical News Today (press release) FDA grants approval to Eli Lilly's Strattera. - Jun 30, 2008 FDA grants approval to Eli Lilly's Strattera. INDIANAPOLIS -- Eli Lilly and Co. has received Food and Drug Administration clearance for Strattera ... $9.94 - Chain Drug Review - Alacra Store FDA issues advisory on ADHD drug, Strattera - Nov 11, 2005 The Food and Drug Administration (FDA) issued an advisory that the labeling for atomoxetine (Strattera) will be revised and a boxed warning and additional ... AAP News - AAP News (subscription) Study Suggests Atomoxetine Significantly Improved Functioning in … - May 31, 2006 At the end of the study, Strattera significantly reduced ADHD symptoms such ... Strattera also significantly reduced anxiety symptoms like excessive worry ... DG News Article: FDA Warns About ADHD Drug Strattera - AP Online | HighBeam … - Sep 29, 2005 FDA Warns About ADHD Drug Strattera ... find AP Online articles. JOHN J. LUMPKIN, Associated Press Writer AP Online 09-29-2005 Dateline: WASHINGTON The Fo. Pay-Per-View - AP Online - HighBeam Research Strattera sales fall back over continuing safety concerns - Apr 26, 2005 Lilly say it expects sales of Strattera to fall in 2005 because of continuing concerns over the safety of ADHD treatments. The US company issued the warning ... Pharmafocus Rare side-effect warnings for Strattera - Feb 8, 2005 UK health professionals have been warned about rare but serious liver problems observed in Lilly's Strattera. The drug has been licensed for the treatment ... Pharmafocus Press Release: Study Suggests Strattera(R) was Effective in Treating ... - Oct 27, 2006 Study Suggests Strattera(R) was Effective in Treating ADHD in Children and Adolescents with ADHD and Reading Disorders. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Study Suggests Strattera(R) Improved ADHD Symptoms … - May 23, 2007 Study Suggests Strattera(R) Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … : FDA grants approval to Eli Lilly's Strattera.(RX RETAIL PHARMACY:... - Jun 30, 2008 FDA grants approval to Eli Lilly's Strattera.(RX RETAIL PHARMACY: Branded Drugs)(Food and Drug Administration)(Eli Lilly and Co.) ... find Chain Drug Review ... Pay-Per-View - Chain Drug Review - HighBeam Research Drug Labeling; Strattera label wears new safety warning - Jan 17, 2005 2005 JAN 17 - (NewsRx.com & NewsRx.net) -- Eli Lilly and Company has added a bolded warning to the product label for Strattera, an attention ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Lilly to Add Warning to Strattera Label | Article from AP Online |... - Sep 29, 2005 Lilly to Add Warning to Strattera Label ... find AP Online articles. AP Online 09-29-2005 Dateline: INDIANAPOLIS Eli Lilly and Co. said Thursday it will add ... Pay-Per-View - AP Online - HighBeam Research Drug Labeling; Strattera label wears new safety warning - Jan 21, 2005 2005 JAN 21 - (NewsRx.com & NewsRx.net) -- Eli Lilly and Company has added a bolded warning to the product label for Strattera, an attention ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Strattera labeling now includes risk of hepatic injury.(Breaking... - Jan 10, 2005 Healthcare professionals were recently notified about a new warning for atomoxetine (Strattera, Eli Lilly), indicated for the treatment of ADHD in adults ... Free with registration - Drug Topics - AccessMyLibrary.com Commercial Insight: ADHD - Strattera Reigns Supreme as Branded … - Jul 22, 2005 With annual revenues of over $2.6 billion in 2004, and a compound annual growth rate of 36.7% since 2002, the ADHD market is one of the most rapidly growing ... MarketResearch.com Four middle-school girls cited in prescription drug exchange - Apr 20, 2008 The girl who was supposed to deliver the alcohol gave a Strattera pill to a third girl ... The girl who took the Strattera pill was ticketed for misdemeanor ... Boulder Daily Camera - Boulder Daily Camera (subscription) Warning on Strattera for Attention-Deficit Hyperactivity Disorder. - Nov 1, 2005 The article deals with the public health advisory issued by the US Food and Drug Administration to physicians on reports of suicidal thinking in children ... Subscription - FDA Consumer - EBSCO Publishing Press Release: Lilly Announces Important Strattera(R) Label Update. -... - Sep 29, 2005 Lilly Announces Important Strattera(R) Label Update. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research New warning for Strattera.(Digest)(Brief Article) - Jan 31, 2005 The Food and Drug Administration has ordered new warning labels concerning the potential for severe liver injury to patients prescribed Strattera. ... Free with registration - Chain Drug Review - AccessMyLibrary.com what are strattera use for. does it cause weight loss? - Oct 20, 2008 Strattera is not a terribly new drug, it came out several years ago as an alternative treatment for attention deficit and impulse control issues. ... HealthCentral.com … 2 new dosage strengths of atomoxetine (Strattera, Lilly).(FAD... - Apr 1, 2005 FDA approved 2 new dosage strengths of atomoxetine (Strattera, Lilly). The attention-deficit/hyperactivity (ADHD) disorder therapy is now available in 80- ... Free with registration - Formulary - AccessMyLibrary.com FDA Safety Labeling Changes: Strattera, Antidepressants - May 11, 2005 May 11, 2005 — The US Food and Drug Administration (FDA) approved in February revisions to safety labeling to advise that use of atomoxetine HCl may be ... Medscape AACAP responds to FDA's Strattera advisory.(NEWS NOTES)(Brief Article... - Nov 1, 2005 The FDA recently released an advisory regarding reports of suicidal thinking in children and adolescents taking Strattera (atamoxetine) (See From the FDA, ... Free with registration - Brown University Child and Adolescent... - AccessMyLibrary.com Questions & Answers: Is Strattera dangerous? - Dec 1, 2005 A. In September 2005, the FDA directed the manufacturer of atomoxetine (Strattera), a new treatment marketed in 2002 for attention deficit hyperactivity ... Free with registration - Harvard Mental Health Letter - AccessMyLibrary.com DNA Research; Safety of Strattera for treating ADHD clarified by DNA ... - Apr 8, 2005 2005 APR 8 - (NewsRx.com) -- Stratterra, produced by Genelex Corporation, was recently approved by the US Food and Drug administration (FDA) for the ... Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones DNA Research; Safety of Strattera for treating ADHD clarified by DNA ... - Apr 4, 2005 2005 APR 4 - (NewsRx.com) -- Stratterra, produced by Genelex Corporation, was recently approved by the US Food and Drug administration (FDA) for the ... Pay-Per-View - Proteomics Weekly - Factiva, from Dow Jones … FDA issues public health advisory on Strattera (Atomoxetine) for... - Sep 30, 2005 FDA issues public health advisory on Strattera (Atomoxetine) for attention deficit disorder. from M2 Presswire. Highbeam Research – FREE Trial. Pay-Per-View - M2 Presswire - HighBeam Research DNA Research; Safety of Strattera for treating ADHD clarified by DNA ... - Apr 10, 2005 2005 APR 10 - (NewsRx.com) -- Stratterra, produced by Genelex Corporation, was recently approved by the US Food and Drug administration (FDA) for the ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones Article: British agency cites new risks with atomoxetine.(News) -... - Mar 1, 2006 Article: Strattera Controlled Symptoms of ADHD With Minimal Effect . ... The safety and efficacy of Strattera in the maintenance of ADHD was demonstrated . ... Pay-Per-View - Pediatric News - HighBeam Research Atomoxetine (generic): Strattera (brand).(Your Medication Information) - Apr 1, 2005 COMMON USAGE: Atomoxetine is indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD). The efficacy and safety of atomoxetine has not ... Free with registration - Brown University Psychopharmacology... - AccessMyLibrary.com Suicidal ideation among children taking atomoxetine (Strattera) - Dec 6, 2005 Reason for posting: As a nonstimulant, atomoxetine is a popular new treatment for attention-deficit hyperactivity disorder (ADHD). ... CMAJ Atomoxetine (Strattera) Improves Executive Function in ADHD Patients:... - Nov 10, 2005 By Steve Pridgeon. VANCOUVER, CANADA -- November 10, 2005 -- Self-reported and parent-reported measures demonstrate improved executive function in children ... DG News … Release: New advice on use of strattera (atomoxetine). - M2... - Feb 3, 2005 New advice on use of strattera (atomoxetine). from M2 Presswire. Highbeam Research – FREE Trial. Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Strattera Safety Helped by DNA Testing, According to … - Mar 9, 2005 Strattera Safety Helped by DNA Testing, According to FDA Approved Product Labeling Notes Genelex Founder, Howard Coleman. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Eli Lilly announced that Strattera (atomoxetine HCI) is now indicated... - Jun 16, 2008 Eli Lilly announced that Strattera (atomoxetine HCI) is now indicated for maintenance treatment of attention-deficit/hyperactivity disorder (ADHD) in ... $9.94 - Drug Topics - Alacra Store A Familiar Refrain at Lilly: The Pipeline - Oct 17, 2005 Another growing concern is Strattera, a treatment for attention deficit hyperactivity ... Early on, Strattera, which was approved for the US market in 2002, ... TheStreet.com - TheStreet.com (subscription) Lilly adds warnings to Strattera.(Brief Article) - Nov 10, 2005 The Medicines and Healthcare products Regulatory Agency is looking into the health risks and benefits of Strattera (atomoxetine). $4.95 - Community Pharmacy - ECNext Press Release: Research and Markets : Strattera the most rapidly... - Aug 15, 2005 Research and Markets : Strattera the most rapidly growing drug in the US ADHD market with 2004 revenues of $632m. from M2 Presswire. Pay-Per-View - M2 Presswire - HighBeam Research Brand Names/Synonyms: Strattera is also known by the following brand names and/or synonymsAtomoxetine; Strattera; Tomoxetina [Spanish]; Tomoxetine; Tomoxetine [Inn]; Tomoxetinum [Latin] Drug Category: Strattera is categorized under the following by the FDA: Antidepressants; Central Nervous System Agents; ATC:N06BA09 Dosage Forms: CAPSULE Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: N-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |